TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTS

類似資料

• PERORAL FORMS OF CYTOSTATIC DRUGS IN THERAPY OF METASTATIC MAMMARY GLAND CANCER: ROLE IN CLINICAL PRACTICE
  著者:: G. M. TELETAEVA, 等
  出版事項: (2016-12-01)
• Efferent therapy in the first-line drug treatment of metastatic colorectal cancer
  著者:: Z. S. Kotova, 等
  出版事項: (2018-07-01)
• Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome
  著者:: F.V. Moiseenko, 等
  出版事項: (2022-01-01)
• NEW ADVANCES IN THE TREATMENT OF BREAST CANCER: THE ROLE EPOTHILONES
  著者:: T. Y. SEMIGLAZOVA, 等
  出版事項: (2017-06-01)
• Successful treatment of high-risk gestational trophoblastic disease in a patient with intolerance to standard chemotherapy (clinical case)
  著者:: G. M. Teletaeva, 等
  出版事項: (2021-01-01)